Akoya BioSciences, Inc. (AKYA) Financials

AKYA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 180.4 million 126.6 million
2023-09-30 177.2 million 115.3 million
2023-06-30 188.9 million 117.0 million
2023-03-31 154.3 million 112.2 million

AKYA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.1 million 2.6 million
2023-09-30 -14.6 million 2.9 million
2023-06-30 -13.2 million 2.6 million
2023-03-31 -20.6 million 2.4 million

AKYA Net Income

No data available :(

AKYA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 83.1 million - 10.5 million
2023-09-30 78.6 million - 11.3 million
2023-06-30 93.3 million 63.6 million 12.0 million
2023-03-31 60.2 million 63.5 million 11.8 million

AKYA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 49.1 million
2023-09-30 49.0 million
2023-06-30 40.6 million
2023-03-31 38.3 million

AKYA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 594000 4.7 million 18.9 million -
2023-09-30 832000 5.2 million 19.0 million -
2023-06-30 1.4 million 6.3 million 22.7 million -
2023-03-31 804000 5.8 million 22.0 million -

AKYA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 26.5 million 11.7 million
2023-09-30 25.2 million 9.9 million
2023-06-30 23.5 million 11.4 million
2023-03-31 21.4 million 9.1 million

AKYA

Price: $4.04

52 week price:
3.04
8.80

Earnings Per Share: -1.43 USD

P/E Ratio: -3.46

Exchange: NMS

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 51598

Market Capitalization: 203.0 million

Links: